Maral Halladjian

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling.

Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 18, 2026

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

Journal: ESMO open

Published: June 06, 2025

Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.

Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.

Journal: NAR cancer

Published: March 06, 2025

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.

Journal: Nature cancer

Published: November 13, 2024

Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.

Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.

Journal: Oral oncology

Published: March 19, 2024

Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors.

Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors.

Journal: The Journal of pathology

Published: January 03, 2024

Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome.

Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome.

Journal: Human pathology

Published: October 06, 2023

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.

Journal: BMC biology

Published: November 29, 2022

Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.

Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 29, 2022

RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit.

RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit.

Journal: PLoS genetics

Published: April 29, 2021

Functional link between DEAH/RHA helicase Prp43 activation and ATP base binding.

Functional link between DEAH/RHA helicase Prp43 activation and ATP base binding.

Journal: Nucleic acids research

Published: April 07, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026